The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis

References

1. 1.↵
   2. Stojanov DA,
   3. Aracki-Trenkic A,
   4. Vojinovic S, et al

   . Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol 2016;26:807–15 doi:10.1007/s00330-015-3879-9 pmid:26105022

   CrossRefPubMed
2. 2.↵
   2. Schlemm L,
   3. Chien C,
   4. Bellmann-Strobl J, et al

   . Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients. Mult Scler 2016 Sep 1. [Epub ahead of print] doi:10.1177/1352458516670738 pmid:27679460

   CrossRefPubMed
3. 3.↵
   2. Roccatagliata L,
   3. Vuolo L,
   4. Bonzano L, et al

   . Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype. Radiology 2009;251:503–10 doi:10.1148/radiol.2511081269 pmid:19401576

   CrossRefPubMed
4. 4.↵
   2. Malayeri AA,
   3. Brooks KM,
   4. Bryant LH, et al

   . National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain. J Am Coll Radiol 2016;13:237–41 doi:10.1016/j.jacr.2015.11.009 pmid:26810815

   CrossRefPubMed
5. 5.↵
   2. Polman CH,
   3. Reingold SC,
   4. Edan G, et al

   . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–46 doi:10.1002/ana.20703 pmid:16283615

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Stroup DF,
   3. Berlin JA,
   4. Morton SC, et al

   . Meta-analysis of observational studies in epidemiology: a proposal for reporting–Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12 doi:10.1001/jama.283.15.2008 pmid:10789670

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Liberati A,
   3. Altman DG,
   4. Tetzlaff J, et al

   . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65–94 pmid:19622512

   PubMed
8. 8.↵
   2. Bammer R,
   3. Augustin M,
   4. Strasser-Fuchs S, et al

   . Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 2000;44:583–91 doi:10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO%3B2-O pmid:11025514

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Blystad I,
   3. Hakansson I,
   4. Tisell A, et al

   . Quantitative MRI for analysis of active multiple sclerosis lesions without gadolinium-based contrast agent. AJNR Am J Neuroradiol 2016;37:94–100 doi:10.3174/ajnr.A4501 pmid:26471751

   Abstract/FREE Full Text
10. 10.↵
    2. Droogan AG,
    3. Clark CA,
    4. Werring DJ, et al

    . Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging 1999;17:653–61 doi:10.1016/S0730-725X(99)00011-9 pmid:10372518

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Faizy TD,
    3. Thaler C,
    4. Kumar D, et al

    . Heterogeneity of multiple sclerosis lesions in multislice myelin water imaging. PLoS One 2016;11:e0151496 doi:10.1371/journal.pone.0151496 pmid:26990645

    CrossRefPubMed
12. 12.↵
    2. Fazekas F,
    3. Ropele S,
    4. Enzinger C, et al

    . Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 2002;8:479–84 doi:10.1191/1352458502ms860oa pmid:12474987

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Filippi M,
    3. Cercignani M,
    4. Inglese M, et al

    . Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304–11 doi:10.1212/WNL.56.3.304 pmid:11171893

    Abstract/FREE Full Text
14. 14.↵
    2. Filippi M,
    3. Iannucci G,
    4. Cercignani M, et al

    . A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 2000;57:1017–21 doi:10.1001/archneur.57.7.1017 pmid:10891984

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Filippi M,
    3. Rocca MA,
    4. Martino G, et al

    . Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809–14 doi:10.1002/ana.410430616 pmid:9629851

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Fox RJ,
    3. Cronin T,
    4. Lin J, et al

    . Measuring myelin repair and axonal loss with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:85–91 doi:10.3174/ajnr.A2238 pmid:20947644

    Abstract/FREE Full Text
17. 17.↵
    2. Giacomini PS,
    3. Levesque IR,
    4. Ribeiro L, et al

    . Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels. Arch Neurol 2009;66:375–81 pmid:19273757

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Goodkin DE,
    3. Rooney WD,
    4. Sloan R, et al

    . A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689–97 doi:10.1212/WNL.51.6.1689 pmid:9855524

    Abstract/FREE Full Text
19. 19.↵
    2. Hiehle JF Jr.,
    3. Grossman RI,
    4. Ramer KN, et al

    . Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69–77 pmid:7900604

    Abstract
20. 20.↵
    2. Jurcoane A,
    3. Wagner M,
    4. Schmidt C, et al

    . Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. J Magn Reson Imaging 2013;38:1454–61 doi:10.1002/jmri.24107 pmid:23554005

    CrossRefPubMed
21. 21.↵
    2. Levesque IR,
    3. Giacomini PS,
    4. Narayanan S, et al

    . Quantitative magnetization transfer and myelin water imaging of the evolution of acute multiple sclerosis lesions. Magn Reson Med 2010;63:633–40 doi:10.1002/mrm.22244 pmid:20146232

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Liu Y,
    3. Mitchell PJ,
    4. Kilpatrick TJ, et al

    . Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis. J Clin Neurosci 2012;19:1689–94 doi:10.1016/j.jocn.2012.03.022 pmid:23084347

    CrossRefPubMed
23. 23.↵
    2. Michoux N,
    3. Guillet A,
    4. Rommel D, et al

    . Texture analysis of T2-weighted MR images to assess acute inflammation in brain MS lesions. PLoS One 2015;10:e0145497 doi:10.1371/journal.pone.0145497 pmid:26693908

    CrossRefPubMed
24. 24.↵
    2. Naismith RT,
    3. Xu J,
    4. Tutlam NT, et al

    . Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010;74:1694–701 doi:10.1212/WNL.0b013e3181e042c4 pmid:20498437

    Abstract/FREE Full Text
25. 25.↵
    2. Nusbaum AO,
    3. Lu D,
    4. Tang CY, et al

    . Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on T1-weighted MR images. AJR Am J Roentgenol 2000;175:821–25 doi:10.2214/ajr.175.3.1750821 pmid:10954474

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Oh J,
    3. Han ET,
    4. Lee MC, et al

    . Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging 2007;17:156–63 doi:10.1111/j.1552-6569.2007.00098.x pmid:17441837

    CrossRefPubMed
27. 27.↵
    2. Papanikolaou N,
    3. Papadaki E,
    4. Karampekios S, et al

    . T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio. Eur Radiol 2004;14:115–22 doi:10.1007/s00330-003-1946-0 pmid:14600774

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Petrella JR,
    3. Grossman RI,
    4. McGowan JC, et al

    . Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041–49 pmid:8791914

    Abstract
29. 29.↵
    2. Phuttharak W,
    3. Galassi W,
    4. Laopaiboon V, et al

    . ADC measurements in various patterns of multiple sclerosis lesions. J Med Assoc Thai 2006;89:196–204 pmid:16579006

    PubMed
30. 30.↵
    2. Pike GB,
    3. De Stefano N,
    4. Narayanan S, et al

    . Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 2000;215:824–30 doi:10.1148/radiology.215.3.r00jn02824 pmid:10831705

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Rovira A,
    3. Alonso J,
    4. Cucurella G, et al

    . Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol 1999;20:1939–45 pmid:10588122

    Abstract/FREE Full Text
32. 32.↵
    2. Roychowdhury S,
    3. Maldjian JA,
    4. Grossman RI

    . Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000;21:869–74 pmid:10815662

    Abstract/FREE Full Text
33. 33.↵
    2. Sahin T,
    3. Bozgeyik Z,
    4. Menzilcioglu MS, et al

    . Importance of diffusion weighted magnetic resonance imaging in evaluation of the treatment efficacy in multiple sclerosis patients with acute attacks. Pol J Radiol 2015;80:544–48 doi:10.12659/PJR.895325 pmid:26740826

    CrossRefPubMed
34. 34.↵
    2. Testaverde L,
    3. Caporali L,
    4. Venditti E, et al

    . Diffusion tensor imaging applications in multiple sclerosis patients using 3T magnetic resonance: a preliminary study. Eur Radiol 2012;22:990–97 doi:10.1007/s00330-011-2342-9 pmid:22160194

    CrossRefPubMed
35. 35.↵
    2. Tievsky AL,
    3. Ptak T,
    4. Farkas J

    . Investigation of apparent diffusion coefficient and diffusion tensor anisotropy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999;20:1491–99 pmid:10512236

    Abstract/FREE Full Text
36. 36.↵
    2. van den Elskamp IJ,
    3. Knol DL,
    4. Vrenken H, et al

    . Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. Mult Scler 2010;16:660–69 doi:10.1177/1352458510364630 pmid:20350960

    CrossRefPubMed
37. 37.↵
    2. van Waesberghe JH,
    3. van Walderveen MA,
    4. Castelijns JA, et al

    . Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675–83 pmid:9576653

    Abstract
38. 38.↵
    2. Vargas WS,
    3. Monohan E,
    4. Pandya S, et al

    . Measuring longitudinal myelin water fraction in new multiple sclerosis lesions. Neuroimage Clin 2015;9:369–75 doi:10.1016/j.nicl.2015.09.003 pmid:26594620

    CrossRefPubMed
39. 39.↵
    2. Vavasour IM,
    3. Laule C,
    4. Li DK, et al

    . Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging 2011;33:713–18 doi:10.1002/jmri.22441 pmid:21563257

    CrossRefPubMed
40. 40.↵
    2. Werring DJ,
    3. Clark CA,
    4. Barker GJ, et al

    . Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–32 doi:10.1212/WNL.52.8.1626 pmid:10331689

    Abstract/FREE Full Text
41. 41.↵
    2. Wiggermann V,
    3. Hernández Torres E,
    4. Vavasour IM, et al

    . Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013;81:211–18 doi:10.1212/WNL.0b013e31829bfd63 pmid:23761621

    Abstract/FREE Full Text
42. 42.↵
    2. Yurtsever I,
    3. Hakyemez B,
    4. Taskapilioglu O, et al

    . The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack. Eur J Radiol 2008;65:421–26 doi:10.1016/j.ejrad.2007.05.002 pmid:17587524

    CrossRefPubMed
43. 43.↵
    2. Zhang Y,
    3. Gauthier SA,
    4. Gupta A, et al

    . Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging 2016;44:426–32 doi:10.1002/jmri.25144 pmid:26800367

    CrossRefPubMed
44. 44.↵
    2. Zivadinov R,
    3. Bergsland N,
    4. Stosic M, et al

    . Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurol Res 2008;30:816–26 doi:10.1179/174313208X341003 pmid:18826808

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Zhang Y,
    3. Gauthier SA,
    4. Gupta A, et al

    . Magnetic susceptibility from quantitative susceptibility mapping can differentiate new enhancing from nonenhancing multiple sclerosis lesions without gadolinium injection. AJNR Am J Neuroradiol 2016 Jun 30. [Epub ahead of print] pmid:27365331

    Abstract/FREE Full Text
46. 46.↵
    2. Fryback DG,
    3. Thornbury JR

    . The efficacy of diagnostic imaging. Med Decis Making 1991;11:88–94 doi:10.1177/0272989X9101100203 pmid:1907710

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Vellinga MM,
    3. Oude Engberink RD,
    4. Seewann A, et al

    . Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 2008;131:800–07 doi:10.1093/brain/awn009 pmid:18245785

    Abstract/FREE Full Text